**Rapid revenue growth from Claude models, particularly Opus 5 and coding-focused releases, combined with Anthropic’s June 2026 confidential S-1 filing, is driving trader consensus toward a near-term IPO at $1.75–2.25 trillion.** The company’s annualized run rate surged past $65 billion by late July 2026—more than sevenfold from end-2025—supported by enterprise adoption, agentic capabilities, and partnerships, outpacing OpenAI on both revenue and private valuation after the May $65 billion round at $965 billion. Bankers have discussed $2 trillion targets and raises exceeding $86–100 billion, with the prospectus expected post-Labor Day and a potential late-September or early-October listing. While 2028 revenue projections of $190–200 billion and a $30 trillion TAM underpin the higher range, traders weigh execution risks around margins, competition, and market conditions against Anthropic’s demonstrated scaling and safety positioning.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於$2.00–$2.25T 51.3%
$1.75–$2.00T 47%
No IPO by December 31, 2027 10.1%
$2.25–$2.50T 5.0%
$23,748 交易量
$23,748 交易量
2027-12-31
<$1.25T
1%
$1.25–$1.50T
<1%
$1.50–$1.75T
2%
$1.75–$2.00T
47%
$2.00–$2.25T
44%
$2.25–$2.50T
5%
$2.50T+
6%
No IPO by December 31, 2027
10%
$2.00–$2.25T 51.3%
$1.75–$2.00T 47%
No IPO by December 31, 2027 10.1%
$2.25–$2.50T 5.0%
$23,748 交易量
$23,748 交易量
2027-12-31
<$1.25T
$906 交易量
1%
$1.25–$1.50T
$953 交易量
<1%
$1.50–$1.75T
$2,912 交易量
2%
$1.75–$2.00T
$10,256 交易量
47%
$2.00–$2.25T
$6,063 交易量
44%
$2.25–$2.50T
$827 交易量
5%
$2.50T+
$1,013 交易量
6%
No IPO by December 31, 2027
$818 交易量
10%
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.**Rapid revenue growth from Claude models, particularly Opus 5 and coding-focused releases, combined with Anthropic’s June 2026 confidential S-1 filing, is driving trader consensus toward a near-term IPO at $1.75–2.25 trillion.** The company’s annualized run rate surged past $65 billion by late July 2026—more than sevenfold from end-2025—supported by enterprise adoption, agentic capabilities, and partnerships, outpacing OpenAI on both revenue and private valuation after the May $65 billion round at $965 billion. Bankers have discussed $2 trillion targets and raises exceeding $86–100 billion, with the prospectus expected post-Labor Day and a potential late-September or early-October listing. While 2028 revenue projections of $190–200 billion and a $30 trillion TAM underpin the higher range, traders weigh execution risks around margins, competition, and market conditions against Anthropic’s demonstrated scaling and safety positioning.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
市場開放時間： Aug 19, 2026, 9:45 AM ET
交易量
$23,748結束日期
2028-01-01市場開放時間
Aug 19, 2026, 9:45 AM ETThis market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.**Rapid revenue growth from Claude models, particularly Opus 5 and coding-focused releases, combined with Anthropic’s June 2026 confidential S-1 filing, is driving trader consensus toward a near-term IPO at $1.75–2.25 trillion.** The company’s annualized run rate surged past $65 billion by late July 2026—more than sevenfold from end-2025—supported by enterprise adoption, agentic capabilities, and partnerships, outpacing OpenAI on both revenue and private valuation after the May $65 billion round at $965 billion. Bankers have discussed $2 trillion targets and raises exceeding $86–100 billion, with the prospectus expected post-Labor Day and a potential late-September or early-October listing. While 2028 revenue projections of $190–200 billion and a $30 trillion TAM underpin the higher range, traders weigh execution risks around margins, competition, and market conditions against Anthropic’s demonstrated scaling and safety positioning.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
交易量
$23,748結束日期
2028-01-01市場開放時間
Aug 19, 2026, 9:45 AM ET**Rapid revenue growth from Claude models, particularly Opus 5 and coding-focused releases, combined with Anthropic’s June 2026 confidential S-1 filing, is driving trader consensus toward a near-term IPO at $1.75–2.25 trillion.** The company’s annualized run rate surged past $65 billion by late July 2026—more than sevenfold from end-2025—supported by enterprise adoption, agentic capabilities, and partnerships, outpacing OpenAI on both revenue and private valuation after the May $65 billion round at $965 billion. Bankers have discussed $2 trillion targets and raises exceeding $86–100 billion, with the prospectus expected post-Labor Day and a potential late-September or early-October listing. While 2028 revenue projections of $190–200 billion and a $30 trillion TAM underpin the higher range, traders weigh execution risks around margins, competition, and market conditions against Anthropic’s demonstrated scaling and safety positioning.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions